Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cellular membranes and structural proteins encompass a broad and diverse array of fundamental biological components that maintain the physical architecture and functional compartmentalization of organisms. Cellular membranes, primarily composed of phospholipid bilayers and sterols, act as semi-permeable barriers and scaffolds for signaling, while structural proteins like tubulin, actin, and collagen provide mechanical strength and facilitate intracellular transport (Alberts et al., Molecular Biology of the Cell). In pharmacology, these components are critical targets; for instance, polyene antifungals like Amphotericin B bind to ergosterol in fungal membranes to cause lethal ion leakage (StatPearls, Amphotericin B), and taxanes like Paclitaxel stabilize microtubules to arrest the cell cycle in malignant cells (NIH, Microtubule-Targeting Agents). Because these structures are ubiquitous across all cell types, therapeutic interventions often face significant challenges regarding systemic toxicity and the requirement for high selectivity to distinguish between pathogens and host cells. This category is considered 'incorrect' as a single therapeutic target because it represents a high-level grouping of distinct molecular entities rather than a specific receptor or enzyme.
Drugs targeting these components typically act by disrupting the physical integrity of lipid bilayers (e.g., pore formation), or by binding to structural proteins to modulate their polymerization or depolymerization dynamics, thereby inhibiting essential processes like mitosis or cell wall synthesis.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cellular membranes and structural proteins.